Business Description
Tenax Therapeutics is a US-based pharmaceutical company focused on developing new treatments for heart and lung conditions. Its lead programs include levosimendan, which has completed Phase II trials for pulmonary hypertension in heart failure patients, and imatinib, a targeted therapy originally used in certain blood cancers. Founded in 1967 and based in Chapel Hill, North Carolina, the company rebranded from Oxygen Biotherapeutics in 2014.
